Basilea Pharmaceutica AG (SWX:BSLN)
Switzerland · Delayed Price · Currency is CHF 66.70
+2.20 (3.41%)
Sep 11, 2026, 5:30 PM CET
Basilea Pharmaceutica AG Market Cap
Basilea Pharmaceutica AG has a market cap or net worth of 800.98 million as of September 11, 2026. Its market cap has increased by 40.79% in one year.
Market Cap
800.98M
Enterprise Value
711.37M
Revenue
247.42M
Ranking
n/a
PE Ratio
16.08
Stock Price
66.70
ChartMarket Cap Chart
Since March 25, 2004, Basilea Pharmaceutica AG's market cap has increased from 533.29M to 800.98M, an increase of 50.19%. That is a compound annual growth rate of 1.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 800.98M | 19.17% |
| Dec 30, 2025 | 672.13M | 34.10% |
| Dec 30, 2024 | 501.21M | 18.52% |
| Dec 29, 2023 | 422.90M | -22.52% |
| Dec 30, 2022 | 545.84M | 12.62% |
| Dec 30, 2021 | 484.67M | -15.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 5.94B |
| Idorsia | 1.32B |
| Newron Pharmaceuticals | 246.34M |
| Santhera Pharmaceuticals Holding AG | 241.95M |
| BioVersys AG | 160.71M |
| Molecular Partners AG | 129.85M |
| Xlife Sciences AG | 78.69M |
| MindMaze Therapeutics Holding | 30.60M |